Compounds > angiotensin ii, des-phe(8)-
Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Disease Exacerbation

angiotensin ii, des-phe(8)- has been researched along with Disease Exacerbation in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (28.57)29.6817
2010's8 (57.14)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Aazami, H; Kamali, M; Khoshmirsafa, M; Mansouri, D; Mohsenzadegan, M; Pornour, M; Seif, F1
Arfsten, H; Bartko, PE; Domenig, O; Goliasch, G; Hengstenberg, C; Hülsmann, M; Mascherbauer, J; Pavo, N; Poglitsch, M; Prausmüller, S; Spinka, G; Strunk, G; Uyanik-Ünal, K; Wurm, R; Zuckermann, A1
Coletta, RD; de Oliveira, CE; Hinsley, EE; Hunt, S; Lambert, DW1
Amundson, E; Kashani, N; Kelland, EE; Lee, S; Levy, AM; Lund, BT; Rodgers, KE; Stone, R1
Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y1
Červenka, L; Husková, Z; Melenovský, V; Nishiyama, A; Sadowski, J; Škaroupková, P1
Gao, Q; Jiang, T; Lu, H; Tan, L; Tian, YY; Yu, JT; Zhang, YD; Zhao, HD; Zhou, JS; Zhu, XC1
Bricca, G; Kobeissy, F; Marcelo, P; Nasser, R; Nehme, A; Zibara, K1
Bader, M; Bürgelová, M; Cervenka, L; Dvorák, P; Kramer, HJ; Malý, J; Opocenský, M; Thumová, M; Vanourková, Z; Zelízko, M1
Casley, D; Gaspari, TA; Tesanovic, S; Vinh, A; Widdop, RE1
Alenina, N; Bader, M; Bürgelová, M; Cervenka, L; Husková, Z; Kramer, HJ; Malý, J; Mrázová, I; Netuka, I; Opočenský, M; Rakušan, D; Santos, RA; Skaroupková, P; Vaněčková, I; Vaňourková, Z1
Gamliel-Lazarovich, A; Kaplan, M; Keidar, S1
Diniz, JS; Pereira, RM; Pinheiro, SV; Santos, RA; Simões e Silva, AC1
Deng, BP; Dong, B; Dong, QL; Feng, JB; Li, SY; Liu, B; Liu, CX; Pan, CM; Song, HD; Yang, YP; Yu, QT; Zhang, C; Zhang, MX; Zhang, Y; Zhao, YX; Zhu, L1

Reviews

2 review(s) available for angiotensin ii, des-phe(8)- and Disease Exacerbation

ArticleYear
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    International archives of allergy and immunology, 2020, Volume: 181, Issue:6

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Janus Kinases; Methotrexate; Molecular Targeted Therapy; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Purines; Pyrazoles; Receptor, Angiotensin, Type 1; SARS-CoV-2; Signal Transduction; STAT Transcription Factors; Sulfonamides

2020
ACE2 of the heart: From angiotensin I to angiotensin (1-7).
    Cardiovascular research, 2007, Feb-01, Volume: 73, Issue:3

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Progression; Heart Failure; Humans; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Ventricular Remodeling

2007

Other Studies

12 other study(ies) available for angiotensin ii, des-phe(8)- and Disease Exacerbation

ArticleYear
Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
    Journal of the American College of Cardiology, 2021, 04-13, Volume: 77, Issue:14

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Female; Heart Failure; Heart Transplantation; Humans; Male; Mass Spectrometry; Middle Aged; Myocardium; Peptide Fragments; Renin-Angiotensin System; Stroke Volume

2021
Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression.
    European journal of oral sciences, 2017, Volume: 125, Issue:4

    Topics: Angiotensin I; Angiotensin II; Cell Culture Techniques; Cell Movement; Disease Progression; Fibroblasts; Head and Neck Neoplasms; Humans; Immunoblotting; Peptide Fragments; Polymerase Chain Reaction; Renin-Angiotensin System; Signal Transduction; Transfection; Tumor Cells, Cultured

2017
Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis.
    Neurobiology of disease, 2019, Volume: 127

    Topics: Angiotensin I; Animals; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Neuroprotection; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Severity of Illness Index; Treatment Outcome

2019
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
    Kidney international, 2015, Volume: 87, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A

2015
Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:7

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Progression; Enzyme Inhibitors; Epoxide Hydrolases; Fatty Acids, Monounsaturated; Female; Fistula; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Solubility; Time Factors; Vena Cava, Inferior

2015
Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease.
    Molecular neurobiology, 2016, Volume: 53, Issue:4

    Topics: Alzheimer Disease; Angiotensin I; Animals; Brain; Disease Models, Animal; Disease Progression; Male; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Phosphorylation; tau Proteins

2016
The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7).
    Vascular pharmacology, 2016, Volume: 85

    Topics: Angiotensin I; Angiotensin II; Angiotensin III; Carotid Artery Diseases; Chromatography, High Pressure Liquid; Disease Progression; Humans; Mass Spectrometry; Peptide Fragments; Plaque, Atherosclerotic; Time Factors

2016
Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
    Journal of hypertension, 2009, Volume: 27, Issue:10

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Disease Progression; Hypertension, Renovascular; Infusion Pumps, Implantable; Peptide Fragments; Rats; Rats, Transgenic; Surgical Instruments; Telemetry; Vasodilator Agents

2009
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:8

    Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Time Factors; Vasodilation; Vasodilator Agents

2010
Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II.
    Kidney & blood pressure research, 2010, Volume: 33, Issue:6

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Disease Progression; Hypertension, Renovascular; Male; Mice; Mice, Knockout; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Surgical Instruments; Vasomotor System

2010
Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
    Pediatric research, 2006, Volume: 60, Issue:6

    Topics: Adolescent; Angiotensin I; Angiotensin II; Angiotensins; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studies; Disease Progression; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System

2006
Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:7

    Topics: Adenoviridae; Angioplasty, Balloon; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Atherosclerosis; Cell Line; Cells, Cultured; Collagen; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Genetic Vectors; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Time Factors; Transduction, Genetic; Up-Regulation

2008